How Priority Review Vouchers Drive Rare Disease Drug Development
How Priority Review Vouchers Drive Rare Disease Drug Development Understanding the Impact of Priority Review Vouchers on Rare Disease Drug Approvals What Is a Priority Review Voucher (PRV)? The Priority Review Voucher (PRV) is a regulatory incentive offered by the U.S. Food and Drug Administration (FDA) to encourage drug development for underserved populations, particularly in…
Read More “How Priority Review Vouchers Drive Rare Disease Drug Development” »